OraSure Technologies Inc.

History

Year	Detail
2000	Epitope, Inc. merged with STC Technologies, Inc. (STC), a closely held private company based in Bethlehem, Pennsylvania. The agreement, which was approved by the board of directors of both companies, was a $260 million, all-stock deal. It resulted in the formation of a new point-of-care medical diagnostics company specializing in oral fluid diagnostics, OraSure Technologies, Inc.
2005	The company partnered with Abbott to distribute OraSure Technologies' OraQuick ADVANCE HIV-1/2 test for hospitals and as a non-exclusive distributor to physician offices in the U.S.
2006	The company acquired the Wartner cryosurgical wart removal product line by Prestige Brands, Inc., which was sold in the U.S. retail or over-the-counter ("OTC") market.
2011	The company acquired privately held DNA Genotek Inc., a provider of oral fluid sample collection, stabilization, and preparation products for molecular diagnostic applications, for approximately US $53 million in cash to strengthen its leadership in oral fluid diagnostics.
2013	OraSure Technologies, Inc. partnered with Thermo Fisher Scientific, to develop and supply up to 12 homogenous fully automated oral fluid drugs of abuse assays to be used with a new Intercept oral fluid specimen collection device.
2019	OraSure Technologies, Inc. acquired two companies, including CoreBiome, a privately held, Minnesota-based early-stage microbiome services provider that accelerates discovery for customers in the pharmaceutical, agricultural, and research communities. Novosanis was a privately held Belgian company founded as a spinoff from the University of Antwerp, Belgium, in 2013.
2019	CoreBiome, a wholly owned subsidiary of OraSure Technologies, Inc., collaborated with Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., to develop a test called LifeKit Prevent. This test represents a microbiome-driven paradigm shift in colon cancer screening.
2020	The company collaborated with Alimentiv Inc. for a research study on Acute Severe Ulcerative Colitis (ASUC) patients.
2022	The company collaborated with Diversigen, Inc., a subsidiary of OraSure Technologies, and Mars Petcare, to sequence microbiome samples from cats and dogs of all breeds and breed makeups in efforts to improve pet care.